staurosporine has been researched along with vernolide-a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, LC; Chen, CH; Chen, Y; Choi, J; Hilliard, TS; Kawakami, JK; Li, Y; Miklossy, G; Paladino, D; Sarkaria, JN; Sun, D; Turkson, J; Wongwiwatthananukit, S; Youn, UJ; Yue, P; Zhang, M | 1 |
1 other study(ies) available for staurosporine and vernolide-a
| Article | Year |
|---|---|
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.
Topics: alpha Karyopherins; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Glioma; Glucosephosphate Dehydrogenase; HSP110 Heat-Shock Proteins; Humans; Magnetic Resonance Spectroscopy; Mice, Nude; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Structure; STAT3 Transcription Factor; Structure-Activity Relationship; Thioredoxin Reductase 1; Trans-Activators; Vimentin; Xenograft Model Antitumor Assays | 2015 |